Freiburg (ots) - Eleva, a manufacturer of superior biologics, is scaling up its production capacity to 2500 l in state-of-the-art single-use reactors. This will produce enough factor H to cover all three clinical phases. Eleva has ordered four more state-of-the-art, 500 l single-use reactors from Sartorius Stedim Systems. The scale-up will enable Eleva to enter ...
Fraunhofer Institut für Angewandte Festkörperphysik IAF
Fraunhofer Institut für Angewandte Festkörperphysik IAF
Technische Universität München
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 22798 - email: presse@tum.de - web: www.tum.de Images: https://mediatum.ub.tum.de/1613116 NEWS RELEASE Digital school books help low-achieving pupils Study on use of tablets in mathematics / new material available online in three languages Low-achieving pupils benefit more in mathematics lessons from learning materials on tablet PCs than ...
The management of forests, cropland and grassland impacts on the amount of greenhouse gases in the atmosphere. These activities must therefore be taken into account in the EU's Climate Target Plan. The EU Parliament and the European Council are currently arguing about the "how". The outcome of this ...
Fraunhofer Institut für Angewandte Festkörperphysik IAF
Fraunhofer Institut für Angewandte Festkörperphysik IAF
Freiburg (ots) - Eleva, a manufacturer of superior biologics, has secured up to EUR 60 million in funding from Zukunftsfonds Heilbronn (ZFHN). The funds will help advance one of its drug candidates, CPV-101, to stages that will facilitate further investment from venture capitalists and/or pharmaceutical companies. Eleva also announced the addition of Dr. Ralf Smit to ...
Press release Freiburg/Berlin, 11 December 2020 Further design of EU climate target for 2030 decisive for climate protection Just in time for the fifth anniversary of the Paris Climate Change Agreement, the European Council has decided to tighten the EU's climate targets. By 2030, the EU is to reduce ...
Fraunhofer Institut für Angewandte Festkörperphysik IAF
Fraunhofer Institut für Angewandte Festkörperphysik IAF
Freiburg (ots) - Eleva, a manufacturer of superior biologics, is exploring the potential of one of its drug candidates for first-in-line therapy of Covid-19. The compound, factor H, is part of the complement system, which is believed to affect the severity of the course of Covid-19. Eleva has developed factor H previously for a different indication and taken it through ...
Fraunhofer Institut für Angewandte Festkörperphysik IAF
Press release Freiburg/Berlin, 14 May 2020 Close gap in the law to improve environmental standards in online shopping Some sellers of electronic equipment from non-EU countries such as China who market their products on the Internet do not contribute to the costs incurred in Germany for the collection ...
Fraunhofer Institut für Angewandte Festkörperphysik IAF
Fraunhofer Institut für Angewandte Festkörperphysik IAF
Fraunhofer Institut für Angewandte Festkörperphysik IAF
Fraunhofer Institut für Angewandte Festkörperphysik IAF
Technische Universität München
TECHNICAL UNIVERSITY OF MUNICH Corporate Communications Center phone: +49 89 289 10510 - e-mail: presse@tum.de - web: www.tum.de This text on the web: https://www.tum.de/nc/en/about-tum/news/press-releases/details/35768/ High resolution images: https://mediatum.ub.tum.de/1522699 NEWS RELEASE Insect decline more extensive than suspected Causes of insect decline and biodiversity loss to be found at the landscape level ...
Fraunhofer Institut für Angewandte Festkörperphysik IAF
Fraunhofer Institut für Angewandte Festkörperphysik IAF
Fraunhofer Institut für Angewandte Festkörperphysik IAF
Fraunhofer Institut für Angewandte Festkörperphysik IAF
